Abbott Laboratories's Total Assets for the quarter that ended in Mar. 2025 was $81,448 Mil.
During the past 12 months, Abbott Laboratories's average Total Assets Growth Rate was 13.40% per year.
During the past 3 years, the average Total Assets Growth Rate was 4.20% per year.
During the past 5 years, the average Total Assets Growth Rate was 2.10% per year.
During the past 10 years, the average Total Assets Growth Rate was 7.40% per year.
During the past 13 years, Abbott Laboratories's highest 3-Year average Total Assets Growth Rate was 23.40%. The lowest was -14.20%. And the median was 11.40%.
The historical data trend for Abbott Laboratories's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Abbott Laboratories's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (NYSE:ABT) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Abbott Laboratories's Asset Turnover for the quarter that ended in Mar. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Abbott Laboratories Total Assets Related Terms
Thank you for viewing the detailed overview of Abbott Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABT has been successfully added to your 